Quick Answer
Kura Oncology, Inc. reported Operating Income of -$303.63 million for fiscal year 2025.
Kura Oncology, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$303.63M | -57.2% |
| 2024 | -$193.19M | -16.5% |
| 2023 | -$165.80M | -18.5% |
| 2022 | -$139.87M | -584937.9% |
| 2014 | -$23.9K | -5.2% |
| 2013 | -$22.7K | -1.8% |
| 2012 | -$22.3K | +4.7% |
| 2011 | -$23.4K | -14.3% |
| 2010 | -$20.5K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$80.00M | -33.6% | -10.1% |
| June 30, 2025 | -$72.67M | -28.8% | -12.3% |
| March 31, 2025 | -$64.70M | -18.8% | -8.0% |
| September 30, 2024 | -$59.88M | — | -6.2% |
| June 30, 2024 | -$56.40M | — | -3.6% |
| March 31, 2024 | -$54.45M | — | -1142889.1% |
| September 30, 2014 | -$4.8K | -6.5% | +9.1% |
| June 30, 2014 | -$5.2K | +3.9% | -26.7% |
- Kura Oncology, Inc. showed a decrease of -57.2% in Operating Income compared to the prior fiscal year.
- Over the 2010–2025 period, Kura Oncology, Inc.’s operating income has declined by 1480376.9% (from -$20.5 thousand to -$303.63 million).
- The most recent figure is from Kura Oncology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: